Revised SPC: Xarelto (rivaroxaban) film-coated tablets – all strengths

SPC updated with license extension for the treatment of venous thromboembolism (VTE) and prevention of VTE recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

electronic Medicines compendium